Related Experiment Video
Updated: May 5, 2026

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
2.6K
Sharing information to reconstruct patient-specific pathways in heterogeneous diseases
Anthony Gitter1, Alfredo Braunstein, Andrea Pagnani
1Microsoft Research, Cambridge, MA, USA.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|December 4, 2013
Summary
This study introduces a new computational method to analyze complex disease data by integrating information across patient samples. This approach improves the identification of disrupted signaling pathways, even with highly variable patient data.
Area of Science:
- Computational biology
- Systems biology
- Genomics and Bioinformatics
Background:
- Abundant omics data (genomic, transcriptomic, epigenomic, proteomic) offer insights into disease drivers.
- Mapping data to protein-protein interaction networks helps identify perturbed signaling pathways.
- Integrating heterogeneous data across biological samples remains a significant challenge, especially in diseases like cancer with long-tailed mutation distributions.
Purpose of the Study:
- To develop a computational approach for inferring signaling pathways from heterogeneous biological data.
- To address the challenge of data integration across diverse patient samples.
- To improve the accuracy and robustness of pathway inference in complex diseases.
Main Methods:
- Developed a novel computational approach based on the prize-collecting Steiner forest problem.
- Utilized a network optimization algorithm to extract pathways from protein-protein interaction networks.
- Implemented a method for sharing information across samples to account for data heterogeneity.
Main Results:
- Successfully recovered signaling pathways that are conserved across samples while retaining sample-specific characteristics.
- Demonstrated improved ability to identify disrupted pathways by leveraging data from related tumors.
- Revealed patient-specific pathway perturbations in breast cancer data.
Conclusions:
- The developed computational approach effectively handles heterogeneous data for signaling pathway inference.
- Leveraging related tumor data enhances the recovery of disrupted pathways and uncovers patient-specific alterations.
- This method holds promise for understanding disease mechanisms in heterogeneous conditions like cancer.
Related Concept Videos
Genome-wide Association Studies-GWAS
12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.7K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129

